International Journal of Cancer

Article	Citations
Issue Information	621
Issue Information	245
	208
	113
Issue Information	108
Latent class analysis‐derived classification improves the cancer‐specific death stratification of lymphomas: A large retrospective cohort study	101
Issue Information	89
Mammographic breast density, body mass index and risk of breast cancer in Korean women aged 75 years and older	88
Assessment of long‐term survival in childhood cancer patients using cancer registry data from eastern China: Period analysis outperforms traditional analysis	74
A comprehensive investigation of histotype‐specific microRNA and their variants in Stage I epithelial ovarian cancers	71
Issue Information	70
	68
Comments on “Methylation scores for smoking, alcohol consumption and body mass index and risk of seven types of cancer”	63
Improving colon cancer screening in Poland. In search of the Holy Grail	61
Pre‐diagnostic circulating resistin concentrations and mortality among individuals with colorectal cancer: Results from the European Prospective Investigation into Cancer and Nutrition study	60
Dipeptidyl peptidase‐4 in the tumor microenvironment of the digestive system: Molecular mechanisms and therapeutic targets	60
Proton pump inhibitors and the risk of acute kidney injury in cancer patients receiving immune checkpoint inhibitors: A Danish population‐based cohort study	60
Urokinase Plasminogen Activator Receptor‐Associated Protein ( uPARAP ) as a Potential Next Generation Molecular Target for Treatment of Gastrointesti	58
Trends in cancer incidence by socioeconomic deprivation in Germany in 2007 to 2018: An ecological registry‐based study	58
Pan‐cancer analysis reveals molecular signatures for predicting matrix stiffness in solid tumors	58
Body mass index and body shape before treatment and nasopharyngeal carcinoma prognosis: A population‐based patient cohort study in southern China	57
Cervical cancer screening: Sharing best practices and addressing common challenges in cervical cancer screening programs	56
Erratum	56
Prospective evaluation of 92 protein biomarkers for early detection of endometrial cancer	55
Gynaecologic and breast cancers in women living with HIV in South Africa: A record linkage study	54

Longitudinal changes in health‐related quality of life after a breast cancer diagnosis in sub‐Saharan Africa: Evidence from the prospective ABC ‐	54
The current status of cell‐free human papillomavirus DNA as a biomarker in cervical cancer and other HPV‐associated tumors: A review	51
Development and psychometric properties of a general cancer stigma scale	50
The cervico‐vaginal DNA methylation WID ‐ qEC t	49
The landscape of genetic aberrations in myxofibrosarcoma	48
Identification of pre‐diagnostic lipid sets associated with liver cancer risk using untargeted lipidomics and chemical set analysis: A nested case‐control study within the ATBC cohort	48
Education level and risk of breast cancer by tumor subtype in the EPIC cohort	47
Polymorphisms within autophagy‐related genes as susceptibility biomarkers for pancreatic cancer: A meta‐analysis of three large European cohorts and functional characterization	46
Delivered relative dose intensity in adolescent and young adult germ cell tumours in England: Assessment of data quality and consistency from clinical trials compared to national cancer registration d	46
Maternal illnesses during pregnancy and the risk of childhood cancer: A medical‐record based analysis (UKCCS)	45
Mediation effect of intestinal microbiota on the relationship between fiber intake and colorectal cancer	44
Physical activity and mortality in melanoma patients within the Norwegian Women and Cancer study (NOWAC)	44
Antiviral prophylaxis for hepatitis B virus reactivation in T‐cell lymphoma patients with resolved hepatitis B virus infection	42
Cost‐effectiveness of risk‐stratified screening for cervical cancer in cohorts vaccinated against human papillomavirus with moderate vaccination coverage	42
Issue Information	42
Clinical validation of a DNA methylation biomarker associated with overall survival of relapsed ovarian cancer patients	41
Survival rates and extra‐regional migration patterns of children and adolescents with cancer in Italy: The 30‐year experience of the Italian Association of Pediatric Hematology and Oncology (AIEOP) wi	41
Improving the clinical meaning of surrogate endpoints: An empirical assessment of clinical progression in phase III oncology trials	40
Timing of surgery and 1‐year postoperative outcomes in patients with breast cancer and preoperative COVID‐19 history: A matched, longitudinal, ambidirectional cohort study	39
The role of neoadjuvant imatinib in gastrointestinal stromal tumor patients: 20 years of experience from a tertial referral center	38
DCLK1 in gastrointestinal cancer: A driver of tumor progression and a promising therapeutic target	38
Prevalence and time trends of human papillomavirus in penile cancer over 26 years—A comprehensive study of 1040 penile cancer cases from Denmark	37
Prevalence and distribution of HPV types in Australian patients with oropharyngeal cancer over time	37
Immune‐related conditions and cancer‐specific mortality among older adults with cancer in the United States	37
New players in the landscape of renal cell carcinoma bone metastasis and therapeutic opportunities	36
tRNA ‐derived fragments: Unveiling new roles and molecular mechanisms in cancer progression	36
Body mass index and colorectal cancer recurrence and mortality: A nationwide cohort study in Denmark	36
Socioeconomic position and risk of cervical cancer in the Nordic countries: Results from the Nordic Occupational Cancer Study	36
Challenges in the future of cancer screening	34
Association of aflatoxin with gallbladder cancer in a case‐control study nested within a Chinese cohort	34
Differences in survival and recurrence of colorectal cancer by stage across population‐based European registries	33
Single‐cell RNA‐seq dissecting heterogeneity of tumor cells and comprehensive dynamics in tumor microenvironment during lymph nodes metastasis in gastric cancer	33
Survival outcomes and prognostic factors of gastric carcinoma with neuroendocrine differentiation	32
Ovarian cancer survival in sub‐Saharan Africa by human development index and histological subtypes: A population‐based registry study	32
Household air pollution and risk of incident lung cancer in urban China: A prospective cohort study	31
Longitudinal associations of plasma metabolites with persistent fatigue among colorectal cancer survivors up to 2 years after treatment	31
Changes in cancer incidence rates by stage during the COVID‐19 pandemic in the US	31
Prenatal diethylstilbestrol exposure and risk of benign breast disease: The National Cancer Institute Diethylstilbestrol Follow‐up Study	31
Ramucirumab‐containing chemotherapy for patients with gastrointestinal neuroendocrine carcinoma refractory/intolerant to platinum‐based chemotherapy: A multicenter observational retrospective study (W	31
International Anal Neoplasia Society's consensus guidelines for anal cancer screening	31
Real‐world efficacy and toxicity of ipilimumab and nivolumab as a first‐line treatment for advanced renal cell carcinoma according to IMDC risk crite	30
Regulome‐wide association study identifies genetically driven accessible regions associated with pancreatic cancer risk	30
Issue Information	30
Systemic circulating microRNA landscape in Lynch syndrome	30
Celecoxib promotes the efficacy of STING‐targeted therapy by increasing antitumor CD8+ T‐cell functions via modulating glucose metabolism of CD11b+	30
Issue Information	30
Multiple primary lung cancer: Updates and perspectives	30
Issue Information	30
Deposition of onco‐histone H3.3‐G34W leads to DNA repair deficiency and activates cGAS/STING‐mediated immune responses	29
Cost‐effectiveness of low‐dose CT lung cancer screening among individuals that have ever smoked in Norway: A model‐based analysis using	29

Clinicopathological and genomic features of early‐onset non‐small cell lung cancer across age and ethnicity	29
Circulating fatty acid binding protein 4 ( FABP ‐4) concentrations and mortality in individuals with colorectal cancer in the European Prospective In	29
Interventions for oral cancer prevention: An evidence and gap map	29
Safe prescribing in cancer patients during the COVID‐19 pandemic and outcomes following restart of cancer care following SARS‐CoV‐2 infection: The COV‐	28
Sex differences in cancer incidence and mortality among patients managed at King Hussein Cancer Center	28
Exploration of immunotherapy in advanced pulmonary lymphoepithelioma‐like carcinoma	28
Harnessing normalcy: The potential of healthy tissue for patient outcomes	28
Cancer‐related fatigue: Towards a more targeted approach based on classification by biomarkers and psychological factors	28
Oral human papillomavirus (HPV) infection and HPV vaccination in an Australian cohort	28
Uncovering possible silent acquired long QT syndrome using exercise stress testing in long‐term pediatric acute lymphoblastic leukemia survivors	28
Issue Information	28
DNA methylation landscape of tumor‐associated macrophages reveals pathways, transcription factors and prognostic value relevant to triple‐negative breast cancer patients	28
Stage‐ and histology‐specific sensitivity for the detection of lung cancer of the NELSON screening protocol—A modeling study	27
Incidence, survival, and mortality of cancer in children and young adolescents in Belgium and the Netherlands in 2004–2015: A comparative population‐based study	27
DNA methylation signatures of cervical pre‐invasive and invasive disease: An epigenome‐wide association study	27
Childhood acute leukemia and type 1 diabetes in children: A nationwide case–control study	27
Survival by Detection Pathway in Patients With Lung Cancer—A Nationwide Descriptive Epidemiological Study in Japan	27
Incidence of late recurrence and second primary cancers 5–10 years after non‐metastatic colorectal cancer	27
Prognostic impact of p16 and high‐risk HPV DNA in ~1300 patients with vulvar cancer	26
FSCN1 as a new druggable target in adrenocortical carcinoma	26
Radiological response of leptomeningeal metastases according to revised RANO criteria is associated with overall survival in breast cancer patients	26
	26
Comment on “Multi‐cancer early detection via a DNA methylation multiplex ddPCR‐based blood test”	26
Risk of second primary lung cancer among cancer survivors stratified by the site of first primary cancer and the lung cancer screening eligibility status	26
	25
Metformin and other anti‐diabetic medication use and breast cancer incidence in the Nurses' Health Studies	25
Issue Information	25
Female reproductive and hormonal factors and lung cancer mortality among never‐smokers: A prospective cohort study of 287 408 Chinese women	25
Erratum	25
Pre‐diagnostic plasma advanced glycation end‐products and soluble receptor for advanced glycation end‐products and mortality in colorectal cancer patients	25
Issue Information	25
From non‐coding RNAs to cancer regulators: The fascinating world of micropeptides	25
Let's talk about sex: Survival among females and males in a real‐world cohort treated with pembrolizumab for non‐small cell lung cancer	25
Person‐years of life lost and lost earnings from cigarette smoking‐attributable cancer deaths, United States, 2019	25
CTHRC1 promotes bone metastasis in prostate cancer	25
Proteomic signature for detection of high‐grade ovarian cancer in germline BRCA mutation carriers	25
Genome‐wide exploration of genetic interactions for bladder cancer risk	25
Erratum to “Surveillance of premalignant gastric cardia lesions: A population‐based prospective cohort study in China”	25
Optimizing the integration of modern systemic therapies and advanced radiotherapy techniques in breast cancer management: An expert opinion from the Institut Curie Breast Radiotherapy Group	24
Efficacy and safety of 5‐aminolevulinic acid‐based photodynamic therapy for cervical low‐grade squamous intraepithelial lesions with HPV infections	24
Cyanotoxin exposure as a novel risk factor for liver fibrosis and steatosis	24
Immune checkpoint inhibitor‐induced vitiligo: A large‐scale real world pharmacovigilance study	24
Analysis of the incidence and mortality trends of esophageal cancer in cancer registry areas of China and Japan	24
Treatment landscape from first‐ to third‐line therapy and quality of life data of patients with pancreatic cancer from the prospective German PARAGON	24
Incidence patterns and temporal trends of childhood cancer in Germany, 1980–2019: Forty years of childhood cancer registration in Germany	24
Annexin A2: The diversity of pathological effects in tumorigenesis and immune response	24
Metabolomic analyses redefine the biological classification of pancreatic cancer and correlate with clinical outcomes	24
Adjuvant FLOT provides survival benefit for oesophagogastric junction and gastric adenocarcinoma patients with low tumour regression after neoadjuvan	24
Eventual success rate and predictors of success for oncology drugs tested in phase I trials	24
Long‐term follow‐up of cervical cancer incidence after normal cytological findings	23
Different treatment efficacies and T790M acquisition of EGFR‐TKIs on NSCLC patients with variable Del‐19 subtypes of EGFR	23
Trends in the incidence of ovarian cancer in sub‐Saharan Africa	23
Development and Release of the Munich UICC Staging Tool ( MUST ): Advancing	23
The effect of diet and nutrition on T cell function in cancer	23
Special issue “The advance of solid tumor research in China”: Prediction of Sunitinib efficacy using computed tomography in patients with pancreatic neuroendocrine tumors	23
CXCR4 expression is associated with proneural‐to‐mesenchymal transition in glioblastoma	23
Risk of Head and Neck Cancer in Former Smokers by Subsite: A Multicenter Analysis From the INHANCE Consortium	23
Combination of pimitespib (TAS‐116) with sunitinib is an effective therapy for imatinib‐resistant gastrointestinal stromal tumors	23
Blood‐based biomarkers in soft tissue sarcoma: Implications for immune checkpoint inhibitor therapy	23
14‐3‐3σ restricts YY1 to the cytoplasm, promoting therapy resistance, and tumor progression in colorectal cancer	23
Anti‐Her2 therapy patterns in metastatic breast cancer—Real‐world data suggest undertreatment	23
Chemotherapy‐induced neutropenia predicts short‐term outcome of patients with pancreatic cancer treated with nanoliposomal irinotecan, fluorouracil, and folinic acid	23
Reply to: Comments on “Psychosocial factors, health behaviors and risk of cancer incidence: Testing interaction and effect modification in an individual participant data meta‐analysis”	22
Loss of copy numbers of retrotransposons (HERVK) on chromosome 7p11.2 impacts EGFR (Epidermal Growth Factor Receptor)‐induced phenotypes for platinum sensitivity and long‐term su	22
Underdiagnosed cancer during COVID‐19 pandemic and return to normality	22
Trim21 deficiency in mice increases HCC carcinogenesis in a NASH context and is associated with immune checkpoint upregulation	22
Sizing and concentration analysis of cfDNA using Biabooster technology: Results from a prospective plasma‐based collection of 77 patients with locally advanced unresectable esophageal cance	22
Incidence of cancer among Nordic police officers	22
	22
Long‐term exposure to air pollution and incidence of gastric and the upper aerodigestive tract cancers in a pooled European cohort: The ELAPSE project	22
Stereoscopic epidemiology of global cancer: Complementary lenses from GBD 2023 and GLOBOCAN 2022	22
Distinguishing the pros and cons of metabolic reprogramming in oncolytic virus immunotherapy	22
Comments on the paper “Extensive epigenomic dysregulation is a hallmark of homologous recombination deficiency in triple‐negative breast cancer” by Y. Chen et al.	22
Serum IgG N‐glycans enable early detection and early relapse prediction of colorectal cancer	22
Comparative sequencing study of mismatch repair and homology‐directed repair genes in endometrial cancer and breast cancer patients from Kazakhstan	21
Combination of PD‐1/PD‐L1 checkpoint inhibition and dendritic cell therapy in mice models and in patients with mesothelioma	21
Pioneering sustainable treatment delivery in childhood leukemia through synchronous telemedicine—A pilot study	21
The United States experience with diagnosing and treating esophageal cancer during the SARS‐CoV‐2 pandemic: A retrospective cohort study	21
Mutational evolution after chemotherapy‐progression in metastatic colorectal cancer revealed by circulating tumor DNA analysis	21
DNA methylation biomarkers for cervical cancer risk prediction in HIV‐positive Nigerian women	21

Issue Information	21
Neuro–astrocytic network in breast cancer brain metastases: Adaptive mechanisms and novel therapeutic targets	21
Reply to: Comments on “Associations of plasma omega‐6 and omega‐3 fatty acids with overall and 19 site‐specific cancers: A population‐based cohort study in UK Biobank”	21
Patient preferences for active surveillance vs standard surgery after neoadjuvant chemoradiotherapy in oesophageal cancer treatment: The NOSANO‐study	21
Late toxicity comparison of alkylating‐based maintenance regimen with cyclophosphamide (VAC) vs ifosfamide (VAI) in Ewing sarcoma survivors treated in the randomized clinical tri	21
Performance of visual inspection, partial genotyping, and their combination for the triage of women living with HIV who are screen positive for human papillomavirus: Results from the AIMA‐CC ANRS 1237	21
Associations between early‐life and in utero infections and cytomegalovirus‐positive acute lymphoblastic leukemia in children	21
A novel mouse model of upper tract urothelial carcinoma highlights the impact of dietary intervention on gut microbiota and carcinogenesis prevention despite carcinogen exposure	20
Clinical and biological determinants of multimodal metronomic chemotherapy efficacy in chemo‐refractory gastrointestinal cancers	20
Rewriting the MASLD ‐associated hepatocellular carcinoma script: Targeting epigenetics and metabolism	20
Evaluation of methods to identify chemotherapy‐related hematologic toxicities in real‐world settings	20
Correction to “Polymorphisms within autophagy‐related genes as susceptibility biomarkers for pancreatic cancer: A meta‐analysis of three large European cohorts and functional characterization”	20
Abiraterone acetate plus prednisolone for metastatic patients starting hormone therapy: 5‐year follow‐up results from the STAMPEDE randomised trial (NCT00268476)	20
Comparing outcomes and toxicities among patients with nasopharyngeal carcinoma treated with daytime versus evening radiotherapy: A retrospective analysis with propensity score matching	20
Sex‐ and site‐specific associations of circulating lipocalin 2 and incident colorectal cancer: Results from the EPIC cohort	20
Genome‐wide study of genetic polymorphisms predictive for outcome from first‐line oxaliplatin‐based chemotherapy in colorectal cancer patients	20
Reproductive history and breast cancer survival: Findings from the African breast cancer—Disparities in outcomes cohort and implications of Africa's fertility transition on breast cancer prognosis	19
Time intervals in the care pathway to cancer diagnosis during the COVID‐19 pandemic: A large retrospective study from a high‐volume center	19
Disseminated intravascular coagulation is an underestimated but fatal adverse event associated with blinatumomab therapy: A pharmacovigilance analysis of FAERS	19
Increased serum NfL and GFAP levels indicate different subtypes of neurologic immune‐related adverse events during treatment with immune checkpoint inhibitors	19
Peri‐weaning cholera toxin consumption suppresses chemically‐induced carcinogenesis in mice	19
Untargeted plasma metabolomics for risk prediction of hepatocellular carcinoma: A prospective study in two Chinese cohorts	19
Patient‐reported outcomes in advanced NSCLC before and during the COVID‐19 pandemic: Real‐world data from the German prospective CRISP Registry (AIO‐TRK‐0315)	19
Thoracic radiotherapy synergizes with first‐line EGFR ‐ TKIs in advanced	19
How to overcome resistance to immune checkpoint inhibitors in colorectal cancer: From mechanisms to translation	19
Issue Information	19
Naxitamab with novel scheduling and stepped‐up dosing of GM ‐ CSF plus vaccine, but no myeloablati	19
Risk factors for low‐risk prostate cancer: A retrospective cohort study within the FinRSPC trial	19
Drug repurposing in oncology: Bridging computational discovery to clinical application	19
Negative impact of corticosteroid use on outcome in patients with advanced BTCs treated with cisplatin, gemcitabine, and durvalumab: A large real‐lif	19
Cumulative risks of false positive recall and screen‐detected breast cancer after multiple screening examinations	19
KMT2D links TGF ‐β signaling to noncanonical activin pathway and regulates pancreatic cancer cell plasticity	19
Issue Information	18
	18
Issue Information	18
Ocular toxicity associated with anti‐HER2 agents in breast cancer: A pharmacovigilance analysis using the FAERS database	18
Fetal growth and pediatric cancer: A pan‐cancer analysis in 7000 cases and 37 000 controls	18
	18
Issue Information	18
Special issue “The advance of solid tumor research in China”: Presurgical therapy in the management of local retroperitoneal recurrence of renal cell carcinoma after radical nephrectomy	18
Blood‐Based Circulating Tumor DNA Assays for Early Colorectal Cancer Detection: A Systematic Review of Performance in Asymptomatic Screening Populati	18
Coffee consumption is associated with a reduced risk of colorectal cancer recurrence and all‐cause mortality	18
Chronic acidosis rewires cancer cell metabolism through PPARα signaling	18
Issue Information	18
	18
Cigarette smoke induces expression of senescence markers and pro‐inflammatory SASP in oral mucosa: Potential implications for early carcinogenic proc	18
Artificial Intelligence in Colonoscopy Surveillance for Lynch Syndrome: Emerging Evidence, Lessons Learned From Average‐Risk Populations, and Future Directions	18
Clinical and genetic features of multiple primary tumours cohorts with a renal cell carcinoma: Implications for molecular genetic investigations	17
Plasma fatty acids depletion: A metabolic signature related to colon cancer	17
	17
Lesion distribution and prognosis of renal cell carcinoma bone metastasis: A novel evaluation model based on random survival forests	17
Extracellular vesicle long RNA markers of early‐stage lung adenocarcinoma	17
Neoadjuvant chemotherapy with docetaxel, oxaliplatin, and S‐1 versus oxaliplatin and S‐1 for locally advanced gastric adenocarcinoma: A multicenter, real‐world cohort study	17
Antibodies against high‐risk human papillomavirus proteins as markers for noncervical HPV‐related cancers in a Black South African population, according to HIV status	17
Washed microbiota transplantation alleviates tyrosine kinase inhibitors associated gastrointestinal adverse effects	17
Inhibition of the Rho / MRTF pathway improves the response of BRAF	17
Human sporadic breast carcinoma histotypes driven by the Human Betaretrovirus homologous to Mouse Mammary Tumor Virus	17
Association between serum urea concentrations and the risk of colorectal cancer, particularly in individuals with type 2 diabetes: A cohort study	17
High‐risk human papillomavirus distribution according to human immunodeficiency virus status among women with cervical cancer in Abidjan, Côte d'Ivoire, 2018 to 2020	17
Comprehensive analysis of a real‐world cohort identifies geranylgeranyl diphosphate synthase 1 as a predictor of chemoresistance in small cell lung cancer	17
Familial aggregation of early‐onset cancers in early‐onset breast cancer families	17
Association between family history with lung cancer incidence and mortality risk in the Asia Cohort Consortium	17
Correction to “Natural resistance to cancer: A window of hope”	17
Training and validation of a novel 14‐gene expression signature associated with prostate cancer metastasis and postoperative recurrence	17
The impact of adjuvant therapy on outcome in UICC stage I pancreatic cancer	16
Novel ectopic expression of zona pellucida 3 glycoprotein in lung cancer promotes tumor growth	16
National surveillance of cancer survival in Iran (IRANCANSURV): Analysis of data of 15 cancer sites from nine population‐based cancer registries	16
Response to: Comments on “Epidemiological trends and survival of oropharyngeal cancer in a high HPV ‐prevalent area: A Danish population‐based study	16
Assessing the risk of cervical neoplasia in the post‐HPV vaccination era	16
The combined signatures of hypoxia and cellular landscape provides a prognostic and therapeutic biomarker in hepatitis B virus‐related hepatocellular carcinoma	16
Human papillomavirus‐based screening at extended intervals missed fewer cervical precancers than cytology in the HPV For Cervical Cancer (HPV FOCAL) trial	16
Head‐to‐head comparison of the diagnostic value of fecal and serum carcinoembryonic antigen for colorectal cancer detection	16
Peritoneal metastases from gastric cancer in a nationwide cohort: Incidence, treatment and survival	16
Progesterone receptor ( PR ) intra‐tumor heterogeneity in premenopausal breast cancer: A secondary analysis of a randomized trial	16
Fragility Index analysis for robustness of evidence in Randomized Controlled Trials in National Comprehensive Cancer Network (NCCN) guidelines for rectal cancer	16
Impact of cancer and other causes of death on mortality of cancer patients: A study based on Japanese population‐based registry data	16
Time‐varying prognostic value of primary tumor sidedness in metastatic colorectal cancer: A population‐based study and meta‐analysis	16
Tissue‐resident memory T cells in immunotherapy and immune‐related adverse events by immune checkpoint inhibitor	16
Home‐based self‐sampling vs clinician sampling for anal precancer screening: The Prevent Anal Cancer Self‐Swab Study	16
	16
Evaluation of targeted next‐generation sequencing for detection of HPV genotypes and sublineages in cervical liquid‐based cytology	16
Exosomes: Mediators in microenvironment of colorectal cancer	16
Comments on “Risk factors for low‐risk prostate cancer: A retrospective cohort study within the FinRSPC trial”	15
Assessment of pain prevalence in cancer patients undergoing anticancer treatments and in cancer survivors after completion of anticancer treatments: A French nationwide cross‐sectional study	15
Convergent dysbiosis of upper aerodigestive microbiota between patients with esophageal and oral cavity squamous cell carcinoma	15
Developing evidence‐based cancer prevention recommendations: Methodology of the World Code Against Cancer Framework to create region‐specific codes	15
Discovery of biomarkers in the era of radioimmunotherapy against lung cancer: A bench‐to‐bedside promise	15
Triage performance and predictive value of the human gene methylation panel among women positive on self‐collected HPV test: Results from a prospective cohort study	15
Genetic variants in CYP2B6 and HSD17B12 associated with risk of squamous cell carcinoma of the head and neck	15
Attributable Fraction of Epstein–Barr Virus in Subtypes of Lymphoma: A Systematic Review and Global Meta‐Analysis	15
Comparison of human papillomavirus‐based cervical cancer screening strategies in Tanzania among women with and without HIV	15
Recent trends in hereditary breast cancer incidence by race and age in KwaZulu‐Natal, South Africa: An 11‐year single‐centre retrospective study (2011‐2021)	15
Adult T‐cell leukemia/lymphoma in French Guiana (1990–2019): Epidemiology, clinical features, and HTLV ‐1 genetic diversity in the two main ethnic po	15
Validation of novel DNA methylation markers in cervical precancer and cancer	14
Metabolic characterization of sphere‐derived prostate cancer stem cells reveals aberrant urea cycle in stemness maintenance	14